NCT01149850 2024-09-19
Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Jonsson Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
11 trialsNCT00387400 2023-08-04
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Canadian Cancer Trials Group
Phase 1 Completed
NCT00822848 2018-09-07
Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Phase 1 Completed
NCT01234740 2018-04-17
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
City of Hope Medical Center
Phase 1 Completed
NCT00897663 2018-01-24
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Alliance for Clinical Trials in Oncology
Completed
NCT01172964 2017-11-09
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
City of Hope Medical Center
Phase 1 Completed
NCT01365949 2016-07-11
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
Children's Oncology Group
Completed
NCT01365962 2016-05-19
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
Children's Oncology Group
Completed
NCT01426945 2016-05-18
Protein Expression in Samples From Young Patients With Rhabdomyosarcoma
Children's Oncology Group
Completed
NCT00900341 2014-03-21
Studying Tumor Tissue Samples From Patients With Soft Tissue Sarcoma
University of Arizona
Completed
NCT00424060 2012-09-24
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed